Enhanced GRK2 expression and S670 phosphorylation status in the given tumor contexts would lead to enhanced HuR functionality, thus, counteracting the canonical HIF protein degradation driven by prolyl hydroxylases [7,9] and recapitulating a pseudo-hypoxic state in normoxia, as a consequence. The gene discussed is ELAVL1; the disease is neoplasm.